Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Midline Catheter, Lidocaine Infusion, Chronic Pain, Outpatient. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Poland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Therapy. A Prospective, Observational Study.
Overview
This study will assess the efficacy, safety and practicality of using midline catheters for repeated intravenous lidocaine infusions in an outpatient pain management setting. Adult patients requiring serial lidocaine infusions for chronic pain will be enrolled and receive treatment through midline catheters over ten sessions. The study will investigate if the midline catheters are a safe and effective option for delivering repeated lidocaine infusions in the outpatient setting, offering a balance between ease of placement, acceptable complication risk and good patients' comfort.
Primary outcome measures
- Successful lidocaine infusion therapy without the need for additional venous access [Time frame: 12 days (from midline insertion to the end of the therapy)]
Secondary outcome measures (8)
- Midline Catheter Maintenance Duration [Time frame: 12 days (from midline insertion to the end of the therapy)]
- Number of Participants with Premature Catheter Removal and Reasons [Time frame: 12 days (from midline insertion to the end of the therapy)]
- A-DIVA scale score [Time frame: The onset of therapy]
- Patient's satisfaction score [Time frame: 12 days (from midline insertion to the end of the therapy)]
- Number of catheter leakage events [Time frame: 12 days (from midline insertion to the end of the therapy)]
- Number of patients with phlebitis [Time frame: 12 days (from midline insertion to the end of the therapy)]
- Total number of upper extremity deep venous thrombosis events [Time frame: 12 days (from midline insertion to the end of the therapy)]
- Number of patients who requested catheter removal [Time frame: 12 days (from midline insertion to the end of the therapy)]
Eligibility criteria
Inclusion criteria
- Patients qualified for lidocaine infusion therapy due to the chronic pain
- Able to provide consent
- ≥18 years of age
Exclusion criteria
- Lack of patient consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Poland · 1 center
- Szpital Kliniczny Dzieciątka Jezus — Warsaw
Identifiers
NCT: NCT07555314 · 1/2026